The ROAMM-EHR Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The ROAMM-EHR Study — Stella

Home/Peripheral Arterial Disease/

View on ClinicalTrials.gov

Recruiting

Back to Peripheral Arterial Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Institute of Aging, Gainesville, Florida

Key details

Sponsor

University of Florida

Collaborators

National Institute on Aging (NIA)

Enrollment target

~50 participants

Started

November 2023

Primary completion

October 2026

Age range

60 Years – 100 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.